Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm
about
Huntingtin's function in axonal transport is conserved in Drosophila melanogasterDrosophila as an In Vivo Model for Human Neurodegenerative DiseaseThe kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's diseaseSystematic analysis of fly models with multiple drivers reveals different effects of ataxin-1 and huntingtin in neuron subtype-specific expressionDelivery of GABAARs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin.Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid raftsIn silico discovery and experimental validation of new protein-protein interactionsA Drosophila model for TDP-43 proteinopathy.Drosophila melanogaster in the study of human neurodegeneration.Using membrane-targeted green fluorescent protein to monitor neurotoxic protein-dependent degeneration of Drosophila eyesDrosophila Models of Huntington's Disease exhibit sleep abnormalitiesCentral regulation of locomotor behavior of Drosophila melanogaster depends on a CASK isoform containing CaMK-like and L27 domainsAUTEN-67 (Autophagy Enhancer-67) Hampers the Progression of Neurodegenerative Symptoms in a Drosophila model of Huntington's Disease.A huntingtin peptide inhibits polyQ-huntingtin associated defectsHuman disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease modelDrosophila models of proteinopathies: the little fly that could.DnaJ-1 and karyopherin α3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6.Native mutant huntingtin in human brain: evidence for prevalence of full-length monomerHuntingtin proteolysis releases non-polyQ fragments that cause toxicity through dynamin 1 dysregulation.The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms.Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.Polyglutamine (polyQ) disorders: the chromatin connection.Early-onset sleep defects in Drosophila models of Huntington's disease reflect alterations of PKA/CREB signaling.Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.Probing mechanisms that underlie human neurodegenerative diseases in DrosophilaDissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila modelLRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction.Symptomatic treatment of Huntington diseaseAggregation formation in the polyglutamine diseases: protection at a cost?Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo.Transglutaminase activation in neurodegenerative diseases.Mitochondrial structural and functional dynamics in Huntington's disease.Recent advances in using Drosophila to model neurodegenerative diseases.Drosophila and genome-wide association studies: a review and resource for the functional dissection of human complex traits.Drosophila melanogaster As a Model Organism to Study RNA Toxicity of Repeat Expansion-Associated Neurodegenerative and Neuromuscular DiseasesGenetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.
P2860
Q27331461-8F1D7613-481F-4A8D-9C5A-988094197E83Q28088777-5C13D516-3C2C-4B19-B1AA-87E687355AF4Q28239367-5EF54DFF-C81A-4E99-823F-97B209A755AAQ28542953-CCB1A720-644D-49D0-B5BF-BFA956879925Q28565331-38E176CD-ABBE-433A-BD2E-D5F604577B9AQ28742804-BB50D37B-34D3-4519-8B2D-03C251D1DD71Q28842760-A42030D3-C9CB-48DA-8A4E-091D0C68C6E5Q33733651-BF857547-CA4A-4D63-B30B-D6E8F49DBC41Q34022667-402B2578-C6FD-4540-B134-E141634918A6Q34088872-455D07E5-88E3-4DE0-A702-273CAB985486Q34165011-5E352C86-BA3F-4E1D-9AB0-4BEE4CD5D5FDQ34477595-0515D960-136A-4E8C-96DC-AB86D96274AFQ34525970-76CD7457-922D-448B-A0E9-0A65554CD587Q34828144-AA135CF5-3573-4CDB-B0C4-F7BD24846AC8Q34858502-066395D2-D8F9-461D-9345-7395344A6632Q35052612-802D686A-48A7-4DBB-A805-932B76204819Q35340099-B2EF1809-335A-4116-A211-9998B28169F9Q35748307-E7B7A265-CBF1-4C4E-A723-5EC9338D1F07Q35791494-AB3231E3-7228-4F30-9E30-D3BCD1457D2FQ35821170-46A69EB4-EF6A-419E-89D3-6F8DD0CA4241Q35921703-406F53E8-FFDD-4B12-947C-586F8E0B2388Q36098669-7F7E46AB-B347-468C-A512-69E6F048043AQ36282199-A446D210-3DB5-48B7-B771-C052C805728AQ36315067-59090F5A-AAFA-44BC-86CB-F79E06B57956Q36328114-680EFCCC-F7FD-45DF-8175-83F2E29DC430Q36581367-432AD736-E440-4F34-B78A-8B2985503A9AQ36823235-654AC257-D8DD-4A2B-A729-C49132C87FF0Q36873362-644D566A-7EE9-418D-8AD6-175D74562925Q37102130-6EDA7749-B7CB-44AF-9235-12FE782EE373Q37124577-299F928F-EB78-4492-A639-B6316298FFBCQ37131233-D5E318EF-9ED2-4E28-AB49-6DD0B01D6C0AQ37238530-667671C8-2CEB-49FE-8E2C-4078F523F828Q37348895-3AED458A-AE52-4E15-89F3-778C0195DF64Q37352964-A78C57D2-6301-4319-B10A-349B177813B8Q37356257-AF0A3C42-197B-4928-9B00-38F775E16876Q37448324-428F3708-5268-4942-917B-B52060A0F023Q37644444-6AA1F630-1659-4EDC-8A30-A5A14AE17773Q37713198-2ED841D9-F6CE-43B3-9696-F9F13B47F58EQ37731940-EDD1B5B9-E8C6-406B-9922-1A674E2B7A17Q37765841-64F9D5A5-9D5A-462F-871D-3C0F0AFD492D
P2860
Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Suppression of neurodegenerati ...... accumulating in the cytoplasm
@ast
Suppression of neurodegenerati ...... accumulating in the cytoplasm
@en
type
label
Suppression of neurodegenerati ...... accumulating in the cytoplasm
@ast
Suppression of neurodegenerati ...... accumulating in the cytoplasm
@en
prefLabel
Suppression of neurodegenerati ...... accumulating in the cytoplasm
@ast
Suppression of neurodegenerati ...... accumulating in the cytoplasm
@en
P2093
P2860
P1433
P1476
Suppression of neurodegenerati ...... accumulating in the cytoplasm
@en
P2093
Cindy V Ly
Eliana Romero
Guang-Ho Cha
Juan Botas
Robert E Hughes
P2860
P356
10.1016/J.NEURON.2007.11.025
P407
P577
2008-01-01T00:00:00Z